Response to preoperative chemoradiation increases the use of sphincter-preserving surgery in patients with locally advanced low rectal carcinoma.
about
Combination of SELDI-TOF-MS and data mining provides early-stage response prediction for rectal tumors undergoing multimodal neoadjuvant therapy.Neo-adjuvant chemoradiotherapy; an opportunity in sphincter preserving procedure for rectal cancer.Revised tumor and node categorization for rectal cancer based on surveillance, epidemiology, and end results and rectal pooled analysis outcomesOverexpression of Transcobalamin 1 is an Independent Negative Prognosticator in Rectal Cancers Receiving Concurrent Chemoradiotherapy.Risk factors associated with sphincter-preserving resection in patients with low rectal cancer.Sphincter-preserving R0 total mesorectal excision with resection of internal genitalia combined with pre- or postoperative chemoradiation for T4 rectal cancer in femalesRectal cancer treatment: improving the picture.Sphincter preservation in distal CT2N0 rectal cancer after preoperative chemoradiotherapy.Neoadjuvant radiochemotherapy in the treatment of fixed and semi-fixed rectal tumors. Analysis of results and prognostic factors.Thymidylate synthase genotype-directed neoadjuvant chemoradiation for patients with rectal adenocarcinoma.Microarray profiling of mononuclear peripheral blood cells identifies novel candidate genes related to chemoradiation response in rectal cancer.Zerumbone increases oxidative stress in a thiol-dependent ROS-independent manner to increase DNA damage and sensitize colorectal cancer cells to radiation.Low-lying rectal cancer with anal canal involvement: abdominoperineal or low anterior resection after neoadjuvant chemoradiotherapy.Methylenetetrahydrofolate reductase genetic polymorphisms and toxicity to 5-FU-based chemoradiation in rectal cancer.Development and progression of colorectal neoplasia.Concurrent chemoradiation with capecitabine and weekly irinotecan as preoperative treatment for rectal cancer: results from a phase I/II study.Utility of rectoscopy in the assessment of response to neoadjuvant treatment for locally advanced rectal cancer.Saving the sphincter in rectal cancer: are we prepared to change practice?Is Preoperative Chemoradiotherapy Beneficial for Sphincter Preservation in Low-Lying Rectal Cancer Patients?Stratification of rectal cancer stage for selection of postoperative chemoradiotherapy: current status.Tumor regression grades: can they influence rectal cancer therapy decision tree?Influence of Preoperative Chemoradiotherapy on the Surgical Strategy According to the Clinical T Stage of Patients With Rectal Cancer.Preoperative chemoradiotherapy creates an opportunity to perform sphincter preserving resection for low-lying locally advanced rectal cancer based on an oncologic outcome study.Radiation therapy for rectal cancer: current status and future directions.Complete pathologic response after combined modality treatment for rectal cancer and long-term survival: a meta-analysis.Normalization of CEA Levels Post-Neoadjuvant Therapy is a Strong Predictor of Pathologic Complete Response in Rectal Cancer.Oncologic outcomes in rectal cancer patients with a ≤1-cm distal resection margin.PET/CT with Fluorodeoxyglucose During Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal CancerCurcumin modulates the radiosensitivity of colorectal cancer cells by suppressing constitutive and inducible NF-kappaB activity.Clinical significance of mucinous components in rectal cancer after preoperative chemoradiotherapy.The impact of surgical diversion before neoadjuvant therapy for rectal cancer.Surgical treatment for rectal cancer: an international perspective on what the medical gastroenterologist needs to know.Perineal reconstruction after abdominoperineal excision using inferior gluteal artery perforator flaps.Factors affecting anastomotic complications following anterior resection in rectal cancer.Elevated CEA levels and low distance of the tumor from the anal verge are predictors of incomplete response to chemoradiation in patients with rectal cancer.Changing operative strategy from abdominoperineal resection to sphincter preservation in T3 low rectal cancer after downstaging by neoadjuvant chemoradiation: a preliminary report.Is the standardized uptake value of FDG-PET/CT predictive of pathological complete response in locally advanced rectal cancer treated with capecitabine-based neoadjuvant chemoradiation?Response to neoadjuvant therapy for rectal cancer: influence on long-term results.A phase II trial of neoadjuvant chemoradiation and local excision for T2N0 rectal cancer: preliminary results of the ACOSOG Z6041 trial.[Spincter preservation after selective chemoradiotherapy of rectal cancer. Interim results of the OCUM study].
P2860
Q31095551-3B075682-EC35-4CDC-B2C0-F4DB1571127FQ33596791-4CC663A4-2F99-45A6-8CFE-AFDA65334079Q33627785-4B62CD0F-8CE8-49BC-BDE1-F8995B2629B4Q33820817-F2FD1E90-F773-40F6-BA8F-24FA309B30FCQ33966264-ECAD2B4A-5088-4BC4-98CC-25EF246C03DAQ34100132-E0C28E30-70DC-472B-BD03-BEF9BFCAF3C4Q34382761-F7E42C2E-95C3-4B56-A559-74A94B538EC4Q34429876-D067473C-2183-48C7-95C8-345D94147C1EQ34599442-B056F791-D391-454E-86B1-B1585032A4CCQ34743494-BBFE405B-60F6-43E6-8989-27E0C75DD95DQ34989668-F85C7652-7274-44A3-B08D-70D54C1317ACQ35084950-95696C7A-6210-4DA4-8696-D65E305EBD91Q35445187-5DC99117-56AE-41B6-830A-6E4C0B92AC41Q35623320-985C7399-F962-4942-8896-FEF43191CBDFQ36241935-1CC48813-50AC-4427-8135-31E365E7EB1FQ36614013-51E4B6BE-97F1-4371-9A0A-192D1E4E6AB2Q36755456-481C3C98-BE43-4215-87F0-F3CF3EC0AC35Q36791084-5A95CA74-2D80-4F51-A33A-1C89C35B346FQ36891772-7CA573C2-AED0-4A6C-AB10-F4FB14F82F4FQ37072492-D9682CF8-8DB8-4A8F-8B5E-E16ABC0DEF6AQ37239808-D2D0ABC1-3125-44F0-B60D-91C013E8F3D2Q37624231-58D60B0F-7669-48E0-A12F-3B00FEE87736Q37636805-92C138F7-2AFF-49BB-82E2-7A922F1FDE38Q37654670-7089B757-1D57-4954-B9E3-556D19C0C42FQ37995506-23870060-65C6-43F2-8D48-24209471083CQ38414118-9C83A3BF-CFF6-4988-969A-F8612267B477Q39143888-6D172475-9E6A-404F-8703-E9E107D91FE4Q39780215-9232A3FB-2A64-4DD4-A771-89A972BC7E5EQ39802485-ED9C4D19-34E5-4652-AFAF-2D223FA86A63Q40569426-A8CEDE30-73ED-46BE-A945-3BC39AFD8613Q40939163-0EF40853-6598-4EE8-856E-56350D91718CQ42587542-6097459C-C6D0-4C7C-8808-BA818B643573Q42631576-0762946A-C7AF-47FB-A265-D1A9BF8A7408Q43814738-46EA4346-F465-44E2-BD04-620FF5BB73A8Q45866914-9B64FD37-5913-4F3D-BC4E-3D5559E55A4CQ46522532-182A206C-1B95-44AD-BC63-B4A572723858Q46581098-F95BBC9E-5684-41A0-86AC-6EF9DD091753Q46657428-30DB9015-ABAD-4200-9F42-788429F381D8Q47096957-E479B2F3-1558-482F-A37E-EB389451A1D0Q52862602-699B683B-821C-4EE4-AA6C-8932C815842A
P2860
Response to preoperative chemoradiation increases the use of sphincter-preserving surgery in patients with locally advanced low rectal carcinoma.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Response to preoperative chemo ...... advanced low rectal carcinoma.
@en
Response to preoperative chemo ...... advanced low rectal carcinoma.
@nl
type
label
Response to preoperative chemo ...... advanced low rectal carcinoma.
@en
Response to preoperative chemo ...... advanced low rectal carcinoma.
@nl
prefLabel
Response to preoperative chemo ...... advanced low rectal carcinoma.
@en
Response to preoperative chemo ...... advanced low rectal carcinoma.
@nl
P2093
P356
P1433
P1476
Response to preoperative chemo ...... advanced low rectal carcinoma.
@en
P2093
Barry W Feig
Christopher H Crane
Edward H Lin
Howard D Thames
Jean-Nicolas Vauthey
John M Skibber
Lee M Ellis
Marc E Delclos
Miguel A Rodriguez-Bigas
Nora A Janjan
P304
P356
10.1002/CNCR.11075
P407
P577
2003-01-01T00:00:00Z